Uli Bialucha

Director Técnico/Científico/I+D en XILIO THERAPEUTICS, INC. .

Consumer Services

Health Technology

Perfil

Uli Bialucha is currently Chief Scientific Officer at Xilio Therapeutics, Inc. since 2022.
Formerly, Dr. Bialucha was Vice President-Drug Discovery at Immunitas Therapeutics, Inc. from 2019 to 2021.
Education includes an undergraduate degree from the University of Sussex and a doctorate from University College London.

Cargos activos de Uli Bialucha

Empresas	Cargo	Inicio
XILIO THERAPEUTICS, INC.	Director Técnico/Científico/I+D	01/04/2021

Todos los cargos activos de Uli Bialucha

Antiguos cargos conocidos de Uli Bialucha.

Empresas	Cargo	Fin
Immunitas Therapeutics, Inc. Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs	Corporate Officer/Principal	01/04/2021

Ver el detalle de la experiencia de Uli Bialucha.

Formación de Uli Bialucha.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Uli Bialucha.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	4
University of Sussex University of Sussex Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University College London University College London Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Xilio Therapeutics, Inc. Xilio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops tumor-selective immuno-oncology therapies	Health Technology
Immunitas Therapeutics, Inc. Immunitas Therapeutics, Inc. BiotechnologyHealth Technology Develops single cell genomic-based drugs	Health Technology